Hoque R. Sleep-disordered breathing in Duchenne muscular dystrophy: an assessment of the literature. J Clin Sleep Med. 2016;12(6):905–11.
Article
PubMed
PubMed Central
Google Scholar
Schechter MS. Technical Report: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome. Pediatrics. 2002;109(4):69e.
Article
Google Scholar
Toussaint M, Steens M, Soudon P. Lung function accurately predicts Hypercapnia in patients with Duchenne muscular dystrophy. Chest. 2007;131(2):368–75.
Article
PubMed
Google Scholar
Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest. 1997;112(4):1024–8.
Article
CAS
PubMed
Google Scholar
Wollinsky KH, Kutter B, Geiger PM. Long-term ventilation of patients with Duchenne muscular dystrophy: experiences at the neuromuscular Centre Ulm. Acta Myol. 2012;31(3):170–8.
PubMed
PubMed Central
Google Scholar
De Bruin PF, Ueki J, Bush A, Khan Y, Watson A, Pride NB. Diaphragm thickness and inspiratory strength in patients with Duchenne muscular dystrophy. Thorax. 1997;52(5):472–5.
Article
PubMed
PubMed Central
Google Scholar
Bianchi C, Baiardi P. Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil. 2008;87(6):461–7.
Article
PubMed
Google Scholar
Beck J, Weinberg J, Hamnegård C-H, Spahija J, Olofson J, Grimby G, et al. Diaphragmatic function in advanced Duchenne muscular dystrophy. Neuromuscul Disord. 2006;16(3):161–7.
Article
PubMed
Google Scholar
Khirani S, Ramirez A, Aubertin G, Boulé M, Chemouny C, Forin V, et al. Respiratory muscle decline in duchenne muscular dystrophy. Pediatr Pulmonol. 2014;49(5):473–81.
Article
PubMed
Google Scholar
Church JE, Trieu J, Sheorey R, Chee AYM, Naim T, Baum DM, et al. Functional β-Adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiation. PLoS One. 2014;9(7):e101379.
Article
PubMed
PubMed Central
CAS
Google Scholar
Silva MT, Wensing LA, Brum PC, Câmara NO, Miyabara EH. Impaired structural and functional regeneration of skeletal muscles fromβ2-adrenoceptor knockout mice. Acta Physiol. 2014;211(4):617–33.
Article
CAS
Google Scholar
Smith WN, Dirks A, Sugiura T, Muller S, Scarpace P, Powers SK. Alteration of contractile force and mass in the senescent diaphragm with β2-agonist treatment. J Appl Physiol. 2002;92(3):941–8.
Article
CAS
PubMed
Google Scholar
Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry. Am Heart J. 2008;155(6):998–1005.
Article
PubMed
PubMed Central
Google Scholar
Kaspar RW, Allen HD, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract. 2009;21(5):241–9.
Article
PubMed
PubMed Central
Google Scholar
Pellegrino MA, D'Antona G, Bortolotto S, Boschi F, Pastoris O, Bottinelli R, et al. Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice. Exp Physiol. 2003;89(1):89–100.
Article
CAS
Google Scholar
Sanderson MJ, Dirksen ER. Mechanosensitive and Beta-adrenergic control of the Ciliary beat frequency of mammalian respiratory tract cells in culture. Am Rev Respir Dis. 1989;139(2):432–40.
Article
CAS
PubMed
Google Scholar
Bennett WD. Effect of β-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol. 2002;110(6):S291–S7.
Article
CAS
PubMed
Google Scholar
Verdugo P, Johnson NT, Tam PY. Beta-adrenergic stimulation of respiratory ciliary activity. J Appl Physiol. 1980;48(5):868–71.
Article
CAS
PubMed
Google Scholar
Farmer P, Pugin J. β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway. Am J Phys Lung Cell Mol Phys. 2000;279(4):L675–L82.
CAS
Google Scholar
Ye RD. β-Adrenergic agonists regulate NF-κB activation through multiple mechanisms. Am J Phys Lung Cell Mol Phys. 2000;279(4):L615–L7.
CAS
Google Scholar
Talmadge J, Scott R, Castelli P, Newman-Tarr T, Lee J. Molecular pharmacology of the beta-adrenergic receptor on THP-1 cells. Int J Immunopharmacol. 1993;15(2):219–28.
Article
CAS
PubMed
Google Scholar
De Paepe B, Creus KK, Martin J-J, De Bleecker JL. Upregulation of chemokines and their receptors in duchenne muscular dystrophy: potential for attenuation of myofiber necrosis. Muscle Nerve. 2012;46(6):914–6.
Article
CAS
Google Scholar
Barros Maranhão J, de Oliveira MD, Maurício AF, de Carvalho SC, Ferretti R, Pereira JA, et al. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy inmdxmice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles. Int J Exp Pathol. 2015;96(5):285–93.
Article
PubMed
PubMed Central
CAS
Google Scholar
Navegantes LCC, Resano NMZ, Migliorini RH, Kettelhut ÍC. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am J Physiol Endocrinol Metab. 2000;279(3):E663–E8.
Article
CAS
PubMed
Google Scholar
Navegantes LCC, Machado CR, Resano NMZ, Migliorini RH, Kettelhut IC. ß2-agonists and cAMP inhibit protein degradation in isolated chick (Gallus domesticus) skeletal muscle. Br Poult Sci. 2003;44(1):149–54.
Article
CAS
PubMed
Google Scholar
Shiraha H, Glading A, Chou J, Jia Z, Wells A. Activation of m-Calpain (Calpain II) by epidermal growth factor is limited by protein kinase a phosphorylation of m-Calpain. Mol Cell Biol. 2002;22(8):2716–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reiken S, Lacampagne A, Zhou H, Kherani A, Lehnart SE, Ward C, et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle. J Cell Biol. 2003;160(6):919–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Parr T, Sensky PL, Arnold MK, Bardsley RG, Buttery PJ. Effects of epinephrine infusion on expression of Calpastatin in porcine cardiac and skeletal muscle. Arch Biochem Biophys. 2000;374(2):299–305.
Article
CAS
PubMed
Google Scholar
Tang W. The Arg16Gly polymorphism of the β2-adrenergic receptor and left ventricular systolic function. Am J Hypertens. 2003;16(11):945–51.
Article
CAS
PubMed
Google Scholar
Daly CJ, McGrath JC. Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci. 2011;32(4):219–26.
Article
CAS
PubMed
Google Scholar
Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HBW, Hildebrandt PR. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol. 2000;36(7):2072–80.
Article
CAS
PubMed
Google Scholar
Kim WJ, Oh Y-M, Sung J, Lee YK, Seo JB, Kim N, et al. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease. Respir Med. 2009;103(1):98–103.
Article
PubMed
Google Scholar
Zhang G, Hayden CM, Khoo S-K, Laing IA, Turner S, Landau L, et al. Association of haplotypes of β2-adrenoceptor polymorphisms with lung function and airway responsiveness in a pediatric cohort. Pediatr Pulmonol. 2006;41(12):1233–41.
Article
CAS
PubMed
Google Scholar
Bello L, Kesari A, Gordish-Dressman H, Cnaan A, Morgenroth LP, Punetha J, et al. Genetic modifiers of ambulation in the cooperative international neuromuscular research group Duchenne natural history study. Ann Neurol. 2015;77(4):684–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gauld LM, Kappers J, Carlin JB, Robertson CF. Height prediction from ulna length. Dev Med Child Neurol. 2004;46(7):475–80.
Article
PubMed
Google Scholar
Kelley EF, Johnson BD, Snyder EM. Beta-2 adrenergic receptor genotype influences power output in healthy subjects. J Strength Cond Res. 2017;31(8):2053–9.
Article
PubMed
PubMed Central
Google Scholar
Hagg A, Colgan TD, Thomson RE, Qian H, Lynch GS, Gregorevic P. Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size. Sci Rep. 2016;6:23042.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gehrig SM, Koopman R, Naim T, Tjoakarfa C, Lynch GS. Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am J Pathol. 2010;176(1):29–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kupa EJ, Roy SH, Kandarian SC, Luca CJD. Effects of muscle fiber type and size on EMG median frequency and conduction velocity. J Appl Physiol. 1995;79(1):23–32.
Article
CAS
PubMed
Google Scholar
Prior TW. Duchenne muscular dystrophy diagnostics: it only gets better but some of the same challenges remain. Clin Chem. 2015;61(6):792–3.
Article
CAS
PubMed
Google Scholar
Lynch GS. Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy. Clin Exp Pharmacol Physiol. 2004;31(8):557–61.
Article
CAS
PubMed
Google Scholar
Vijayan K, Thompson JL, Norenberg KM, Fitts RH, Riley DA. Fiber-type susceptibility to eccentric contraction-induced damage of hindlimb-unloaded rat AL muscles. J Appl Physiol. 2001;90(3):770–6.
Article
CAS
PubMed
Google Scholar
Ryall JG, Lynch GS. The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting. Pharmacol Ther. 2008;120(3):219–32.
Article
CAS
PubMed
Google Scholar
Kim MO, Na SI, Lee MY, Heo JS, Han HJ. Epinephrine increases DNA synthesis via ERK1/2s through cAMP, Ca2+/PKC, and PI3K/Akt signaling pathways in mouse embryonic stem cells. J Cell Biochem. 2008;104(4):1407–20.
Article
CAS
PubMed
Google Scholar
Doran P, Dowling P, Donoghue P, Buffini M, Ohlendieck K. Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2006;1764(4):773–85.
Article
CAS
Google Scholar
Navegantes LCC, Baviera AM, Kettelhut IC. The inhibitory role of sympathetic nervous system in the Ca2+−dependent proteolysis of skeletal muscle. Braz J Med Biol Res. 2009;42(1):21–8.
Article
CAS
PubMed
Google Scholar
Fowler EG, Graves MC, Wetzel GT, Spencer MJ. Pilot trial of albuterol in Duchenne and Becker muscular dystrophy. Neurology. 2004;62(6):1006–8.
Article
CAS
PubMed
Google Scholar
Skura CL, Fowler EG, Wetzel GT, Graves M, Spencer MJ. Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. Neurology. 2008;70(2):137–43.
Article
CAS
PubMed
Google Scholar
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347–61.
Article
PubMed
PubMed Central
Google Scholar
Koeks Z, Bladen CL, Salgado D, van Zwet E, Pogoryelova O, McMacken G, et al. Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database. J Neuromuscul Dis. 2017;4(4):293–306.
Article
PubMed
PubMed Central
Google Scholar
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–89.
Article
CAS
PubMed
Google Scholar